{"lastClose": 4.03000020980835, "len": 989, "date": "2023-03-08", "alpha_1": -0.7834080818797542, "beta_1": 0.8602589718906624, "drawup_1": 0.7155424508464454, "natr_1": 20.79012583787908, "sup_1": -0.8163771586888342, "res_1": 0.746898202055811, "bullPattern_1": [], "bearPattern_1": [], "rsi_1": 37.40457487331047, "adx_1": 16.522186823914037, "drawdown_1": -0.8070175398354672, "stratHoldSharpe_1": -0.6305731614103398, "stratHoldAlpha_1": 250.46832748809246, "stratHoldDrawdown_1": -0.7407364639537586, "alpha_3mo": -0.39149734298032357, "beta_3mo": 1.6889952822081982, "drawup_3mo": 0.20805376931257258, "natr_3mo": 20.79012583787908, "sup_3mo": -0.08933009273397634, "res_3mo": 0.03225801235272413, "bullPattern_3mo": [], "bearPattern_3mo": ["SHORTLINE"], "rsi_3mo": 34.56221157651472, "adx_3mo": 37.52231680437222, "drawdown_3mo": -0.2591911456950502, "stratHoldSharpe_3mo": -1.43911212993725, "stratHoldAlpha_3mo": 250.27101439299452, "stratHoldDrawdown_3mo": -0.23495646104232082, "Market Cap": 328947605, "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Sector": "Health Care", "Name": "NGM Biopharmaceuticals Inc.", "IPO Year": 2019.0, "Country": "United States", "alpha%_1": 0.00937932365904729, "beta%_1": 0.41025498367462154, "drawup%_1": 0.6697781495675211, "natr%_1": 0.999999999999689, "drawdown%_1": 0.01250460233375927, "stratHoldSharpe%_1": 0.13953976692594072, "stratHoldAlpha%_1": 0.012102643774877292, "stratHoldDrawdown%_1": 0.012534277872874854, "alpha%_3mo": 0.15329102085425983, "beta%_3mo": 0.9026716899490967, "drawup%_3mo": 0.40006050116419045, "natr%_3mo": 0.9999999999993077, "drawdown%_3mo": 0.0809009214738956, "stratHoldSharpe%_3mo": 0.10315022237033872, "stratHoldAlpha%_3mo": 0.04640281070783676, "stratHoldDrawdown%_3mo": 0.0848079618972607}